The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder

Onur İsmi1, Veli Yildirim2, Yusuf Vayisoglu1

  • 1Department of Otorhinolaryngology, Mersin Üniversitesi, Mersin, Turkey.

Insights

Methylphenidate, used for attention deficit hyperactivity disorder (ADHD), was evaluated for hearing side effects. The study found no significant ototoxic effects in pediatric patients after treatment, suggesting it is a safe medication.

Area of Science:

  • Pediatric Neurology
  • Otolaryngology
  • Pharmacology

Background:

  • A case of sudden hearing loss after methylphenidate treatment in a child with attention deficit hyperactivity disorder (ADHD) prompted this investigation.
  • Methylphenidate is a common stimulant medication used to manage ADHD symptoms in children.

Purpose of the Study:

  • To investigate the potential ototoxic side effects of methylphenidate in pediatric patients diagnosed with ADHD.
  • To assess changes in auditory function following methylphenidate treatment.

Main Methods:

  • The study included thirty pediatric patients with ADHD.
  • Auditory function was assessed using pure tone audiometry, speech discrimination tests, and auditory brainstem response (ABR) before and three months after initiating methylphenidate treatment.
  • ABR parameters included absolute and interpeak latencies at 80 dB nHL following click stimuli.

Main Results:

  • No statistically significant differences were observed in pure tone audiometry, speech discrimination scores, or ABR results between pre-treatment and post-treatment assessments (p > 0.05 for all parameters).
  • These findings indicate that methylphenidate treatment did not lead to measurable hearing impairment in the studied pediatric population.

Conclusions:

  • Methylphenidate appears to be a safe medication concerning ototoxic side effects in children with ADHD.
  • Further research with larger cohorts and extended follow-up periods is recommended to corroborate these findings.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.0K
Hearing01:31

Hearing

When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
57.3K
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
309
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.4K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.3K